Checkpoint Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Checkpoint expects its common shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market in December 2022. The Board of Directors determined the 1-for-10 ratio to be appropriate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results